STAAR Surgical Co. Form 8-K Summary
Business Context and Reporting Period
STAAR Surgical Co. (STAA) filed a Current Report on Form 8-K on May 13, 2026. The filing announces the publication of financial results for the quarter ended April 3, 2026. The company is incorporated in Delaware and trades on the NASDAQ.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is incorporated by reference but not detailed in the body of this 8-K.
Material Changes
No material changes or comparative financial data are disclosed within the text of this filing. The document serves solely to notify investors of the availability of the quarterly results.
Guidance, Outlook, and Management Commentary
Management, including the Interim Co-Chief Executive Officer and Chief Financial Officer, scheduled a conference call and webcast for May 13, 2026, to discuss the results for the quarter ended May 13, 2026. The filing explicitly states that the information provided in Items 2.02 and 7.01 is not deemed "filed" under Section 18 of the Exchange Act and shall not be incorporated by reference into other filings.
Key Facts for Investor Verification
- Verify the specific financial results for the quarter ended April 3, 2026, by reviewing Exhibit 99.1 (Press Release).
- Note the discrepancy in the filing text where Item 2.02 references the quarter ended April 3, 2026, while Item 7.01 references a discussion of results for the quarter ended May 13, 2026.
- Confirm the leadership structure, as the report is signed by Deborah Andrews in her capacity as Interim Co-Chief Executive Officer and Chief Financial Officer.
- Review the conference call transcript for detailed management commentary and forward-looking statements not included in this 8-K.